kavinilavan commited on
Commit
aa04178
·
1 Parent(s): ef37703

Upload finetune-dataset -agent_0.csv

Browse files
Files changed (1) hide show
  1. finetune-dataset -agent_0.csv +852 -0
finetune-dataset -agent_0.csv ADDED
@@ -0,0 +1,852 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ input,instruction,output
2
+ ,"Probability_life_sciences: 0.95
3
+ PoA:
4
+ 1. Identify clinical trials for frontline MCL patients treated with ibrutinib.
5
+ Array:
6
+ [[""What are the clinical trials for frontline MCL patients treated with ibrutinib?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question
7
+ ""what is the PFS for ibrutinib in frontline MCL patients?""
8
+ Give me the answers in the following format
9
+ -Probability_life_sciences:
10
+ -PoA:
11
+ -Array:"
12
+ ,"Probability_life_sciences: 0.95
13
+ PoA:
14
+ 1. Identify companies conducting phase 1 clinical trials for Alzheimer's.
15
+ Array:
16
+ [[""What companies have phase 1 clinical trials for Alzheimer's?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question
17
+ ""What companies have phase 1 clinical trials for alzheimer's?""
18
+ Give me the answers in the following format
19
+ -Probability_life_sciences:
20
+ -PoA:
21
+ -Array:"
22
+ ,"Probability_life_sciences: 0.95
23
+ PoA:
24
+ 1. Identify Phase 1 neurology trials by Novartis.
25
+ Array:
26
+ [[""List Phase 1 neurology trials by Novartis""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question
27
+ ""List Phase 1 neurology trials by Novartis""
28
+ Give me the answers in the following format
29
+ -Probability_life_sciences:
30
+ -PoA:
31
+ -Array:"
32
+ ,"Probability_life_sciences: 0.95
33
+ PoA:
34
+ 1. Identify clinical-stage drugs targeting neutrophil-mediated disease.
35
+ Array:
36
+ [[""What companies have clinical-stage drugs targeting neutrophil-mediated disease?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question
37
+ ""What companies have clinical-stage drugs targeting neutrophil-mediated disease?""
38
+ Give me the answers in the following format
39
+ -Probability_life_sciences:
40
+ -PoA:
41
+ -Array:"
42
+ ,"Probability_life_sciences: 0.95
43
+ PoA:
44
+ 1. Identify drugs currently under FDA review for their initial NDA or BLA approval.
45
+ Array:
46
+ [[""What drugs are currently under FDA review for their initial NDA or BLA approval?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
47
+ ""What drugs are currently under FDA review for their initial NDA or BLA approval?""
48
+ Give me the answers in the following format
49
+ -Probability_life_sciences:
50
+ -PoA:
51
+ -Array:"
52
+ ,"PoA:
53
+ 1. Explain the effects of multiple sclerosis on dendrites and synapses.
54
+ Array:
55
+ [[""What are the effects of multiple sclerosis on dendrites and synapses?""], [""Internet""], [""NA""], [""Summarize""]]
56
+
57
+ Probability_life_sciences: 0.95","For the given question
58
+ ""Explain the different affects on dendrites and synapses in multiple sclerosis?""
59
+ Give me the answers in the following format
60
+ -Probability_life_sciences:
61
+ -PoA:
62
+ -Array:"
63
+ ,"Probability_life_sciences: 0.95
64
+ PoA:
65
+ 1. Determine if Sutro Biopharma is a publicly traded company.
66
+ Array:
67
+ [[""Is Sutro Biopharma a publicly traded company?""], [""Internet""], [""NA""], [""Summarize""]]
68
+
69
+ Probability_life_sciences: 0.95","For the given question
70
+ ""Is Sutro Biopharma a publicly traded company?""
71
+ Template
72
+ -PoA:
73
+ -Probability_life_sciences:
74
+ -Array:"
75
+ ,"Probability_life_sciences: 0.95
76
+ PoA:
77
+ 1. Identify the projected number of newly diagnosed cases of female breast cancer in the US for 2023.
78
+ 2. Determine the estimated number of deaths expected from female breast cancer in the US for 2023.
79
+ Array:
80
+ [[""What is the projected number of newly diagnosed cases of female breast cancer in the US for 2023?""], [""Internet""], [""2023-01-01"", ""2023-12-31""], [""Summarize""]],
81
+ [[""What is the estimated number of deaths expected from female breast cancer in the US for 2023?""], [""Internet""], [""2023-01-01"", ""2023-12-31""], [""Summarize""]]","For the given question
82
+ ""What is the projected number of newly diagnosed cases of female breast cancer in the US for 2023, and what is the estimated number of deaths expected from this disease in the same year?""
83
+ Template
84
+ -PoA:
85
+ -Probability_life_sciences:
86
+ -Array:"
87
+ ,"Probability_life_sciences: 0.95
88
+ PoA:
89
+ 1. Identify treatment options for 2nd line ER+ breast cancer.
90
+ Array:
91
+ [[""What treatment options exist for 2nd line ER+ breast cancer?""], [""DailyMed""], [""NA""], [""List""]]","For the given question
92
+ ""what treatment options exist for 2nd line ER+ breast cancer""
93
+ Template
94
+ -PoA:
95
+ -Probability_life_sciences:
96
+ -Array:"
97
+ ,"Probability_life_sciences: 0.95
98
+ PoA:
99
+ 1. Identify financial information for Cosentyx in 2023.
100
+ Array:
101
+ [[""What are the financials for Cosentyx in 2023?""], [""Internet""], [""2023-01-01"", ""2023-12-31""], [""Summarize""]]","For the given question
102
+ ""Cosentyx financials 2023""
103
+ Template
104
+ -PoA:
105
+ -Probability_life_sciences:
106
+ -Array:"
107
+ ,"PoA:
108
+ 1. Identify the number of patients using Herceptin.
109
+ Array:
110
+ [[""How many patients are using Herceptin?""], [""DailyMed""], [""NA""], [""Summarize""]]
111
+
112
+ Probability_life_sciences: 0.95","For the given question
113
+ ""How many patients are using Herceptin?""
114
+ Template
115
+ -PoA:
116
+ -Probability_life_sciences:
117
+ -Array:"
118
+ ,"PoA:
119
+ 1. Determine the prevalence of boron deficiency in Australia.
120
+ Array:
121
+ [[""What is the prevalence of boron deficiency in Australia?""], [""Internet""], [""NA""], [""Summarize""]]
122
+
123
+ Probability_life_sciences: 0.85","For the given question
124
+ ""What is the prevalence of boron deficiency in Australia?""
125
+ Template
126
+ -PoA:
127
+ -Probability_life_sciences:
128
+ -Array:"
129
+ ,"Probability_life_sciences: 0.95
130
+ PoA:
131
+ 1. Identify the drug DC-806.
132
+ 2. Determine the phase of clinical development for DC-806.
133
+ Array:
134
+ [[""What is the drug DC-806?""], [""DailyMed""], [""NA""], [""Summarize""]], [[""What phase of clinical development is DC-806 in?""], [""ClinicalTrials""], [""NA""], [""Summarize""]]
135
+
136
+ Probability_life_sciences: 0.95","For the given question
137
+ ""Which phase of clinical development is DC-806 in?""
138
+ Template
139
+ -Probability_life_sciences:
140
+ -Array:
141
+ -PoA:"
142
+ ,"PoA:
143
+ 1. Summarize the design and results of the CASPIAN trial.
144
+ Array:
145
+ [[""What is the design of the CASPIAN trial?""], [""ClinicalTrials""], [""NA""], [""Summarize""]], [[""What are the results of the CASPIAN trial?""], [""ClinicalTrials""], [""NA""], [""Summarize""]]
146
+
147
+ Probability_life_sciences: 0.95","For the given question
148
+ ""Summarize the design and results of the CASPIAN trial.""
149
+ Template
150
+ -Probability_life_sciences:
151
+ -Array:
152
+ -PoA:"
153
+ ,"Probability_life_sciences: 0.95
154
+ PoA:
155
+ 1. Identify the latest developments in Alzheimer's treatment.
156
+ Array:
157
+ [[""What are the latest developments in Alzheimer's treatment?""], [""Internet""], [""2022-07-26"", ""2023-07-26""], [""Summarize""]]
158
+
159
+ Probability_life_sciences: 0.95","For the given question
160
+ ""Describe the latest developments in Alzheimer's treatment""
161
+ Template
162
+ -Probability_life_sciences:
163
+ -Array:
164
+ -PoA:"
165
+ ,"PoA:
166
+ 1. Identify recent deals in the psychedelic space.
167
+ Array:
168
+ [[""What are some recent deals in the psychedelic space?""], [""Internet""], [""2022-07-26"", ""2023-07-26""], [""List""]]
169
+
170
+ Probability_life_sciences: 0.95","For the given question
171
+ ""What are some recent deals in the psychedelic space?""
172
+ Template
173
+ -Probability_life_sciences:
174
+ -Array:
175
+ -PoA:"
176
+ ,"Probability_life_sciences: 0.95
177
+ PoA:
178
+ 1. Identify phase 2 or phase 3 trials for Batten disease currently enrolling patients in the US.
179
+ Array:
180
+ [[""What phase 2 or phase 3 trials for Batten disease are currently enrolling patients in the US?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question
181
+ ""Please list phase 2 or phase 3 trials for Batten disease currently enrolling patients in the US.""
182
+ Template
183
+ -Probability_life_sciences:
184
+ -Array:
185
+ -PoA:"
186
+ ,"PoA:
187
+ 1. Identify the recommended age group for Gardasil vaccination.
188
+ Array:
189
+ [[""What is the recommended age group for Gardasil vaccination?""], [""DailyMed""], [""NA""], [""Summarize""]]
190
+
191
+ Probability_life_sciences: 0.95","For the given question
192
+ ""What are the recommended age group for Gardasil vaccination""
193
+ Template
194
+ -Probability_life_sciences:
195
+ -Array:
196
+ -PoA:"
197
+ ,"Probability_life_sciences: 0.95
198
+ PoA:
199
+ 1. Identify what GDUFA stands for.
200
+ 2. Explain how GDUFA helps the FDA.
201
+ Array:
202
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
203
+
204
+ Probability_life_sciences: 0.95
205
+ PoA:
206
+ 1. Identify what GDUFA stands for.
207
+ 2. Explain how GDUFA helps the FDA.
208
+ Array:
209
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
210
+
211
+ Probability_life_sciences: 0.95
212
+ PoA:
213
+ 1. Identify what GDUFA stands for.
214
+ 2. Explain how GDUFA helps the FDA.
215
+ Array:
216
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
217
+
218
+ Probability_life_sciences: 0.95
219
+ PoA:
220
+ 1. Identify what GDUFA stands for.
221
+ 2. Explain how GDUFA helps the FDA.
222
+ Array:
223
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
224
+
225
+ Probability_life_sciences: 0.95
226
+ PoA:
227
+ 1. Identify what GDUFA stands for.
228
+ 2. Explain how GDUFA helps the FDA.
229
+ Array:
230
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
231
+
232
+ Probability_life_sciences: 0.95
233
+ PoA:
234
+ 1. Identify what GDUFA stands for.
235
+ 2. Explain how GDUFA helps the FDA.
236
+ Array:
237
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
238
+
239
+ Probability_life_sciences: 0.95
240
+ PoA:
241
+ 1. Identify what GDUFA stands for.
242
+ 2. Explain how GDUFA helps the FDA.
243
+ Array:
244
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
245
+
246
+ Probability_life_sciences: 0.95
247
+ PoA:
248
+ 1. Identify what GDUFA stands for.
249
+ 2. Explain how GDUFA helps the FDA.
250
+ Array:
251
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
252
+
253
+ Probability_life_sciences: 0.95
254
+ PoA:
255
+ 1. Identify what GDUFA stands for.
256
+ 2. Explain how GDUFA helps the FDA.
257
+ Array:
258
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
259
+
260
+ Probability_life_sciences: 0.95
261
+ PoA:
262
+ 1. Identify what GDUFA stands for.
263
+ 2. Explain how GDUFA helps the FDA.
264
+ Array:
265
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
266
+
267
+ Probability_life_sciences: 0.95
268
+ PoA:
269
+ 1. Identify what GDUFA stands for.
270
+ 2. Explain how GDUFA helps the FDA.
271
+ Array:
272
+ [[""What does GDUFA stand for?""], [""Internet""], [""NA""], [""Summarize""]], [[""How does GDUFA help the FDA?""], [""Internet""], [""NA""], [""Summarize""]]
273
+
274
+ Probability_life_sciences: 0.01
275
+ PoA:
276
+ 1. Gather latest information on Beyonce's background and career.
277
+ Array:
278
+ [[""Who is Beyonce?""], [""Internet""], [""2022-06-01"", ""2023-06-01""], [""Summarize""]]","For the given question
279
+ ""What Is GDUFA? How does it help the FDA?""
280
+ Template
281
+ -Array:
282
+ -Probability_life_sciences:
283
+ -PoA:
284
+ "
285
+ ,"Probability_life_sciences: 0.95
286
+ PoA:
287
+ 1. Identify drugs approved for HER2+ breast cancer.
288
+ 2. Determine the percentage of patients with HER2+ breast cancer who are also HR+.
289
+ Array:
290
+ [[""What drugs are approved for HER2+ breast cancer?""], [""DailyMed""], [""NA""], [""List""]], [[""What percentage of patients with HER2+ breast cancer are also HR+?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
291
+ ""What percent of patients with HER2+ breast cancer are also HR+?""
292
+ Template
293
+ -Array:
294
+ -Probability_life_sciences:
295
+ -PoA:
296
+ "
297
+ ,"PoA:
298
+ 1. Identify the planned and ongoing phase 3 and 4 studies for Tepezza.
299
+ Array:
300
+ [[""What are the planned and ongoing phase 3 and 4 studies for Tepezza?""], [""ClinicalTrials""], [""NA""], [""List""]]
301
+
302
+ Probability_life_sciences: 0.95","For the given question
303
+ ""What are the planned and ongoing phase 3 and 4 studies for Tepezza?""
304
+ Template
305
+ -Array:
306
+ -Probability_life_sciences:
307
+ -PoA:
308
+ "
309
+ ,"Probability_life_sciences: 0.8
310
+ PoA:
311
+ 1. Gather information on the BioPhase 8800.
312
+ Array:
313
+ [[""What is the BioPhase 8800?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
314
+ ""What is the BioPhase 8800?""
315
+ Template
316
+ -Array:
317
+ -Probability_life_sciences:
318
+ -PoA:
319
+ "
320
+ ,"Current Prompt: How many people have diabetes worldwide?
321
+
322
+ Sub-questions:
323
+ 1. How many people worldwide have diabetes?
324
+ 2. What is the global prevalence of diabetes?
325
+ 3. What is the current number of diabetes cases globally?
326
+ 4. How many individuals are affected by diabetes globally?
327
+
328
+ PoA:
329
+ 1. Determine the number of people worldwide with diabetes.
330
+ Array:
331
+ [[""How many people worldwide have diabetes?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
332
+ ""How many people have diabetes worldwide?""
333
+ Template
334
+ -Array:
335
+ -Probability_life_sciences:
336
+ -PoA:
337
+ "
338
+ ,"Probability_life_sciences: 0.95
339
+ PoA:
340
+ 1. Identify the manufacturer of dornase alpha.
341
+ Array:
342
+ [[""Who manufactures dornase alpha?""], [""DailyMed""], [""NA""], [""Summarize""]]","For the given question
343
+ ""Who manufactures dornase alpha?""
344
+ Template
345
+ -Array:
346
+ -Probability_life_sciences:
347
+ -PoA:
348
+ "
349
+ ,"PoA:
350
+ 1. Identify endocrine therapies used in breast cancer treatment.
351
+ 2. Gather information on the most frequent symptoms associated with endocrine therapy in breast cancer.
352
+ Array:
353
+ [[""What are the endocrine therapies used in breast cancer treatment?""], [""DailyMed""], [""NA""], [""List""]], [[""What are the most frequent symptoms associated with endocrine therapy in breast cancer?""], [""Internet""], [""NA""], [""List""]]
354
+
355
+ Probability_life_sciences: 0.95","For the given question
356
+ ""Can you list the most frequent symptoms from endocrine therapy in breast cancer?""
357
+ Template
358
+ -Array:
359
+ -PoA:
360
+ -Probability_life_sciences:
361
+
362
+ "
363
+ ,"PoA:
364
+ 1. List current trials for hot flashes or vasomotor symptoms.
365
+ Array:
366
+ [[""List current trials for hot flashes or vasomotor symptoms""], [""ClinicalTrials""], [""NA""], [""List""]]
367
+
368
+ Probability_life_sciences: 0.95","For the given question
369
+ ""List current trials for hot flashes or vasomotor symptoms""
370
+ Template
371
+ -Array:
372
+ -PoA:
373
+ -Probability_life_sciences:
374
+
375
+ "
376
+ ,"Probability_life_sciences: 0.95
377
+ PoA:
378
+ 1. Identify multiple myeloma abstracts at ASCO 2023.
379
+ Array:
380
+ [[""List all the multiple myeloma abstracts at ASCO 2023?""], [""Internet""], [""NA""], [""List""]]","For the given question
381
+ ""List all the multiple myeloma abstracts at ASCO 2023?""
382
+ Template
383
+ -Array:
384
+ -PoA:
385
+ -Probability_life_sciences:
386
+
387
+ "
388
+ ,"Probability_life_sciences: 0.95
389
+ PoA:
390
+ 1. Identify the major theme for ASCO 2023.
391
+ Array:
392
+ [[""What was the major theme for ASCO 2023?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
393
+ ""what was the majpor theme for ASCO 2023""
394
+ Template
395
+ -Array:
396
+ -PoA:
397
+ -Probability_life_sciences:
398
+
399
+ "
400
+ ,"Probability_life_sciences: 0.95
401
+ PoA:
402
+ 1. Identify MSI and its significance in colorectal cancer.
403
+ Array:
404
+ [[""What is MSI?""], [""Internet""], [""NA""], [""Summarize""]], [[""What is the significance of MSI in colorectal cancer?""], [""Internet""], [""NA""], [""Summarize""]]
405
+
406
+ Probability_life_sciences: 0.95","For the given question
407
+ ""What is MSI, and what is its significance in colorectal cancer?""
408
+ Template
409
+ -Array:
410
+ -PoA:
411
+ -Probability_life_sciences:
412
+
413
+ "
414
+ ,"Probability_life_sciences: 0.95
415
+ PoA:
416
+ 1. Identify studies exploring B7H3 ADCs in breast cancer.
417
+ Array:
418
+ [[""Are there any studies exploring B7H3 ADCs in breast cancer?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question
419
+ ""Are there any studies exploring B7H3 ADCs in breast cancer""
420
+ Template
421
+ -Array:
422
+ -PoA:
423
+ -Probability_life_sciences:
424
+
425
+ "
426
+ ,"Probability_life_sciences: 0.95
427
+ PoA:
428
+ 1. Identify BMS's highest earning products.
429
+ Array:
430
+ [[""What are BMS's highest earning products?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
431
+ ""What are BMS's highest earning products?""
432
+ Template
433
+ -PoA:
434
+ -Array:
435
+ -Probability_life_sciences:"
436
+ ,"Probability_life_sciences: 0.95
437
+ PoA:
438
+ 1. Identify drugs in development for AML.
439
+ Array:
440
+ [[""What drugs are in development for AML?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question
441
+ ""List drugs in development for AML""
442
+ Template
443
+ -PoA:
444
+ -Array:
445
+ -Probability_life_sciences:"
446
+ ,"Probability_life_sciences: 0.85
447
+ PoA:
448
+ 1. Gather the most recent updates or news on Spevigo.
449
+ Array:
450
+ [[""What is the latest news on Spevigo?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
451
+ ""what are the latest news on spevigo?""
452
+ Template
453
+ -PoA:
454
+ -Array:
455
+ -Probability_life_sciences:"
456
+ ,"PoA:
457
+ 1. Identify drugs approved for Duchenne Muscular Dystrophy.
458
+ Array:
459
+ [[""Which drugs are approved for Duchenne Muscular Dystrophy?""], [""DailyMed""], [""NA""], [""List""]]
460
+
461
+ Probability_life_sciences: 0.95","For the given question
462
+ ""Which drugs are approved for duchenne muscular dystrophy?""
463
+ Template
464
+ -PoA:
465
+ -Array:
466
+ -Probability_life_sciences:"
467
+ ,"Probability_life_sciences: 0.95
468
+ PoA:
469
+ 1. Identify metastatic breast cancer patients.
470
+ 2. Determine the percentage of metastatic breast cancer patients who are HER2 positive.
471
+ Array:
472
+ [[""What percent of metastatic breast cancer patients are HER2 positive?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question
473
+ ""what percent of metastatic breast cancer patients are her2 positive""
474
+ Template
475
+ -PoA:
476
+ -Array:
477
+ -Probability_life_sciences:"
478
+ ,"Probability_life_sciences: 0.95
479
+ PoA:
480
+ 1. Identify indications approved for Pyrukynd.
481
+ Array:
482
+ [[""What indications is Pyrukynd approved for?""], [""DailyMed""], [""NA""], [""Summarize""]]","For the given question
483
+ ""What indications is Pyrukynd approved for""
484
+ Template
485
+ -PoA:
486
+ -Array:
487
+ -Probability_life_sciences:"
488
+ ,"Probability_life_sciences: 0.95
489
+ PoA:
490
+ 1. Identify clinical trials of osimertinib in patients with non-small cell lung cancer and brain metastases.
491
+ Array:
492
+ [[""What clinical trials have been conducted on osimertinib in patients with non-small cell lung cancer and brain metastases?""], [""ClinicalTrials""], [""NA""], [""List""]]
493
+
494
+ [[""What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question answer it using the given template
495
+
496
+ Question
497
+ ""What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases""
498
+ Template
499
+ -Probability_life_sciences:
500
+ -PoA:
501
+ -Array:"
502
+ ,"Probability_life_sciences: 0.95
503
+ PoA:
504
+ 1. Identify the typical price of branded drugs.
505
+ 2. Identify the typical price of generic versions of drugs.
506
+ 3. Calculate the price difference in percent between branded drugs and generic versions.
507
+ Array:
508
+ [[""What is the typical price of branded drugs?""], [""Internet""], [""NA""], [""Summarize""]],
509
+ [[""What is the typical price of generic versions of drugs?""], [""Internet""], [""NA""], [""Summarize""]],
510
+ [[""Calculate the price difference in percent between branded drugs and generic versions.""], [""Internet""], [""NA""], [""Summarize""]]
511
+
512
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
513
+
514
+ Question
515
+ ""What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases""
516
+ Template
517
+ -Probability_life_sciences:
518
+ -PoA:
519
+ -Array:"
520
+ ,"Probability_life_sciences: 0.95
521
+ PoA:
522
+ 1. Identify drugs in the pipeline for smoking cessation.
523
+ Array:
524
+ [[""What drugs are in the pipeline for smoking cessation?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question answer it using the given template
525
+
526
+ Question
527
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
528
+
529
+ Template
530
+ -Probability_life_sciences:
531
+ -PoA:
532
+ -Array:"
533
+ ,"Probability_life_sciences: 0.95
534
+ PoA:
535
+ 1. Identify the Rituximab concentration used in R-CHOP therapy.
536
+ Array:
537
+ [[""What is the Rituximab concentration used in R-CHOP therapy?""], [""DailyMed""], [""NA""], [""Summarize""]]","For the given question answer it using the given template
538
+
539
+ Question
540
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
541
+
542
+ Template
543
+ -Probability_life_sciences:
544
+ -PoA:
545
+ -Array:"
546
+ ,"Probability_life_sciences: 0.95
547
+ PoA:
548
+ 1. Compare the performance of Zeposia and Cosentyx in 2023.
549
+ Array:
550
+ [[""How is Zeposia expected to perform in 2023 compared to Cosentyx?""], [""Internet""], [""2023-01-01"", ""2023-12-31""], [""Summarize""]]","For the given question answer it using the given template
551
+
552
+ Question
553
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
554
+
555
+ Template
556
+ -Probability_life_sciences:
557
+ -PoA:
558
+ -Array:"
559
+ ,"Probability_life_sciences: 0.95
560
+ PoA:
561
+ 1. Identify Sanofi's Q1 2023 revenue/sales in the US.
562
+ 2. Identify Sanofi's Q1 2023 revenue/sales in the EU.
563
+ 3. Identify Sanofi's Q1 2023 revenue/sales in APAC.
564
+ Array:
565
+ [[""What was Sanofi's Q1 2023 revenue/sales in the US?""], [""Internet""], [""2023-01-01"", ""2023-03-31""], [""Summarize""]],
566
+ [[""What was Sanofi's Q1 2023 revenue/sales in the EU?""], [""Internet""], [""2023-01-01"", ""2023-03-31""], [""Summarize""]],
567
+ [[""What was Sanofi's Q1 2023 revenue/sales in APAC?""], [""Internet""], [""2023-01-01"", ""2023-03-31""], [""Summarize""]]","For the given question answer it using the given template
568
+
569
+ Question
570
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
571
+
572
+ Template
573
+ -Probability_life_sciences:
574
+ -PoA:
575
+ -Array:"
576
+ ,"Probability_life_sciences: 0.95
577
+ PoA:
578
+ 1. Research the biosimilar space for Stada.
579
+ Array:
580
+ [[""How does the biosimilar space look for Stada?""], [""Internet""], [""NA""], [""Summarize""]]
581
+
582
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
583
+
584
+ Question
585
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
586
+
587
+ Template
588
+ -Probability_life_sciences:
589
+ -PoA:
590
+ -Array:"
591
+ ,"Probability_life_sciences: 0.95
592
+ PoA:
593
+ 1. Identify the mechanism of action of mesenchymal stromal cells in graft versus host disease.
594
+ Array:
595
+ [[""How do mesenchymal stromal cells work in graft versus host disease?""], [""Internet""], [""NA""], [""Summarize""]]
596
+
597
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
598
+
599
+ Question
600
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
601
+
602
+ Template
603
+ -Probability_life_sciences:
604
+ -PoA:
605
+ -Array:"
606
+ ,"Probability_life_sciences: 0.95
607
+ PoA:
608
+ 1. Identify the differences between grey and white matter lesions in multiple sclerosis.
609
+ Array:
610
+ [[""What are the differences between grey and white matter lesions in multiple sclerosis?""], [""Internet""], [""NA""], [""Summarize""]]
611
+
612
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
613
+
614
+ Question
615
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
616
+
617
+ Template
618
+ -Probability_life_sciences:
619
+ -PoA:
620
+ -Array:"
621
+ ,"Current Prompt: How is eliquis administered?
622
+
623
+ Probability_life_sciences: 0.95
624
+
625
+ PoA:
626
+ 1. Determine the administration method of eliquis.
627
+ Array:
628
+ [[""How is eliquis administered?""], [""DailyMed""], [""NA""], [""Summarize""]]
629
+
630
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
631
+
632
+ Question
633
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
634
+
635
+ Template
636
+ -Probability_life_sciences:
637
+ -PoA:
638
+ -Array:"
639
+ ,"Probability_life_sciences: 0.95
640
+ PoA:
641
+ 1. Identify the preclinical pipeline for Harbour Biomed.
642
+ Array:
643
+ [[""What is the preclinical pipeline for Harbour Biomed?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question answer it using the given template
644
+
645
+ Question
646
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
647
+
648
+ Template
649
+ -Probability_life_sciences:
650
+ -PoA:
651
+ -Array:"
652
+ ,"Probability_life_sciences: 0.95
653
+ PoA:
654
+ 1. Identify ASCO 2023 abstracts related to isatuximab.
655
+ Array:
656
+ [[""What are the ASCO 2023 abstracts related to isatuximab?""], [""Internet""], [""NA""], [""Summarize""]]","For the given question answer it using the given template
657
+
658
+ Question
659
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
660
+
661
+ Template
662
+ -Probability_life_sciences:
663
+ -PoA:
664
+ -Array:"
665
+ ,"Probability_life_sciences: 0.95
666
+ PoA:
667
+ 1. Identify BMS's financial outlook for 2023.
668
+ Array:
669
+ [[""What is BMS's financial outlook for 2023?""], [""Internet""], [""2023-01-01"", ""2023-12-31""], [""Summarize""]]","For the given question answer it using the given template
670
+
671
+ Question
672
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
673
+
674
+ Template
675
+ -Probability_life_sciences:
676
+ -PoA:
677
+ -Array:"
678
+ ,"Probability_life_sciences: 0.95
679
+ PoA:
680
+ 1. Determine the fatality rate of Marburg Virus Disease.
681
+ 2. Identify any vaccines in clinical trials for Marburg Virus Disease.
682
+ Array:
683
+ [[""What is the fatality rate of Marburg Virus Disease?""], [""Internet""], [""NA""], [""Summarize""]], [[""Are there any vaccines in clinical trials for Marburg Virus Disease?""], [""ClinicalTrials""], [""NA""], [""List""]]
684
+
685
+ Probability_life_sciences: 0.95
686
+ PoA:
687
+ 1. Determine the fatality rate of Marburg Virus Disease.
688
+ 2. Identify any vaccines in clinical trials for Marburg Virus Disease.
689
+ Array:
690
+ [[""What is the fatality rate of Marburg Virus Disease?""], [""Internet""], [""NA""], [""Summarize""]], [[""Are there any vaccines in clinical trials for Marburg Virus Disease?""], [""ClinicalTrials""], [""NA""], [""List""]]
691
+
692
+ Probability_life_sciences: 0.95
693
+ PoA:
694
+ 1. Determine the fatality rate of Marburg Virus Disease.
695
+ 2. Identify any vaccines in clinical trials for Marburg Virus Disease.
696
+ Array:
697
+ [[""What is the fatality rate of Marburg Virus Disease?""], [""Internet""], [""NA""], [""Summarize""]], [[""Are there any vaccines in clinical trials for Marburg Virus Disease?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question answer it using the given template
698
+
699
+ Question
700
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
701
+
702
+ Template
703
+ -Probability_life_sciences:
704
+ -PoA:
705
+ -Array:"
706
+ ,"PoA:
707
+ 1. Determine the incidence rate of KRAS G12 lung patients.
708
+ Array:
709
+ [[""What is the incidence rate of KRAS G12 lung patients?""], [""Internet""], [""NA""], [""Summarize""]]
710
+
711
+ Probability_life_sciences: 0.85","For the given question answer it using the given template
712
+
713
+ Question
714
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
715
+
716
+ Template
717
+ -Probability_life_sciences:
718
+ -PoA:
719
+ -Array:"
720
+ ,"PoA:
721
+ 1. Identify how HCTZ works.
722
+ Array:
723
+ [[""How does HCTZ work?""], [""DailyMed""], [""NA""], [""Summarize""]]
724
+
725
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
726
+
727
+ Question
728
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
729
+
730
+ Template
731
+ -Probability_life_sciences:
732
+ -PoA:
733
+ -Array:"
734
+ ,"Probability_life_sciences: 0.85
735
+ PoA:
736
+ 1. Determine if Sutro Biopharma has any marketed products.
737
+ Array:
738
+ [[""Does Sutro Biopharma have any marketed products?""], [""DailyMed""], [""NA""], [""Summarize""]]","For the given question answer it using the given template
739
+
740
+ Question
741
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
742
+
743
+ Template
744
+ -Probability_life_sciences:
745
+ -PoA:
746
+ -Array:"
747
+ ,"Probability_life_sciences: 0.95
748
+ PoA:
749
+ 1. Identify clinical trials that include TIGIT in combination with another agent as a third line or later therapeutic.
750
+ Array:
751
+ [[""Can you list all of the clinical trials which include a TIGIT in combination with another agent as a third line or later therapeutic?""], [""ClinicalTrials""], [""NA""], [""List""]]","For the given question answer it using the given template
752
+
753
+ Question
754
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
755
+
756
+ Template
757
+ -Probability_life_sciences:
758
+ -PoA:
759
+ -Array:"
760
+ ,"Probability_life_sciences: 0.95
761
+ PoA:
762
+ 1. Identify active clinical trials for inflammatory diseases.
763
+ 2. Determine the expected completion date of enrollment for each trial.
764
+ Array:
765
+ [[""What active clinical trials are open for inflammatory diseases?""], [""ClinicalTrials""], [""NA""], [""List""]], [[""What is the expected completion date of enrollment for each trial?""], [""ClinicalTrials""], [""2023-01-01"", ""2023-12-31""], [""List""]]
766
+
767
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
768
+
769
+ Question
770
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
771
+
772
+ Template
773
+ -Probability_life_sciences:
774
+ -PoA:
775
+ -Array:"
776
+ ,"Probability_life_sciences: 0.95
777
+ PoA:
778
+ 1. Identify the company that acquired Horizon Therapeutics.
779
+ 2. Determine the financial terms of the deal.
780
+ 3. Analyze the main pipeline or portfolio that drove the M&A from Horizon.
781
+ Array:
782
+ [[""Which company acquired Horizon Therapeutics?""], [""Internet""], [""NA""], [""Summarize""]], [[""What were the financial terms of the deal?""], [""Internet""], [""NA""], [""Summarize""]], [[""What was the main pipeline or portfolio that drove the M&A from Horizon?""], [""Internet""], [""NA""], [""Summarize""]]
783
+
784
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
785
+
786
+ Question
787
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
788
+
789
+ Template
790
+ -Probability_life_sciences:
791
+ -PoA:
792
+ -Array:"
793
+ ,"Probability_life_sciences: 0.95
794
+ PoA:
795
+ 1. Identify adverse events associated with Tepezza.
796
+ Array:
797
+ [[""What are the adverse events for patients taking Tepezza?""], [""DailyMed""], [""NA""], [""Summarize""]]","For the given question answer it using the given template
798
+
799
+ Question
800
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
801
+
802
+ Template
803
+ -Probability_life_sciences:
804
+ -PoA:
805
+ -Array:"
806
+ ,"Probability_life_sciences: 0.95
807
+ PoA:
808
+ 1. Identify Jelmyto sales data for 2021 and 2022.
809
+ 2. Calculate the growth rate of Jelmyto sales from 2021 to 2022.
810
+ Array:
811
+ [[""What is the sales data for Jelmyto in 2021 and 2022?""], [""Internet""], [""2021-01-01"", ""2022-12-31""], [""Summarize""]], [[""Calculate the growth rate of Jelmyto sales from 2021 to 2022.""], [""NA""], [""NA""], [""Summarize""]]","For the given question answer it using the given template
812
+
813
+ Question
814
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
815
+
816
+ Template
817
+ -Probability_life_sciences:
818
+ -PoA:
819
+ -Array:"
820
+ ,"Current Prompt: What is TP-1287, who owns it and what designation did the FDA grant for TP-1287?
821
+
822
+ Probability_life_sciences: 0.95
823
+ PoA:
824
+ 1. Identify TP-1287 and its properties.
825
+ 2. Determine the owner of TP-1287.
826
+ 3. Find out the FDA designation granted for TP-1287.
827
+ Array:
828
+ [[""What is TP-1287?""], [""DailyMed""], [""NA""], [""Summarize""]], [[""Who owns TP-1287?""], [""Internet""], [""NA""], [""Summarize""]], [[""What FDA designation was granted for TP-1287?""], [""Internet""], [""NA""], [""Summarize""]]
829
+
830
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
831
+
832
+ Question
833
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
834
+
835
+ Template
836
+ -Probability_life_sciences:
837
+ -PoA:
838
+ -Array:"
839
+ ,"PoA:
840
+ 1. Compare V116 to other pneumococcal vaccines on the market.
841
+ Array:
842
+ [[""How does V116 compare to other pneumococcal vaccines on the market?""], [""DailyMed""], [""NA""], [""Summarize""]]
843
+
844
+ Probability_life_sciences: 0.95","For the given question answer it using the given template
845
+
846
+ Question
847
+ What evidence is there for the efficacy of osimertinib in patients with non-small cell lung cancer and brain metastases
848
+
849
+ Template
850
+ -Probability_life_sciences:
851
+ -PoA:
852
+ -Array:"